Position in NVO
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,631,973
+$353,331 QoQ
Shares Held
34,042
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#417
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AUGUSTINE ASSET MANAGEMENT INC holds $23,866,482 across 7 Drug Manufacturers - General names. NVO ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,655 | $9,336,167 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
48,484 | $6,125,468 | |
| 3 | AMGN |
Amgen Inc
|
6,890 | $2,495,006 | |
| 4 | SNY |
Sanofi
|
44,133 | $1,882,713 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
34,042 | $1,631,973 | |
| 6 | LLY |
ELI LILLY & Co
|
1,270 | $1,523,276 | |
| 7 | JNJ |
Johnson & Johnson
|
3,433 | $871,879 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,631,973 | 34,042 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,278,642 | 34,793 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,722,186 | 33,848 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,921,729 | 34,632 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,369,494 | 19,842 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,370,606 | 19,738 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,693,217 | 19,684 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||